These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 23330986)

  • 1. Hepatic and intestinal CYP3A expression and activity in broilers.
    Osselaere A; De Bock L; Eeckhaut V; De Backer P; Van Bocxlaer J; Boussery K; Croubels S
    J Vet Pharmacol Ther; 2013 Dec; 36(6):588-93. PubMed ID: 23330986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP3A in horse intestines.
    Tydén E; Olsén L; Tallkvist J; Larsson P; Tjälve H
    Toxicol Appl Pharmacol; 2004 Dec; 201(2):112-9. PubMed ID: 15541751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.
    Paine MF; Khalighi M; Fisher JM; Shen DD; Kunze KL; Marsh CL; Perkins JD; Thummel KE
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1552-62. PubMed ID: 9400033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal expression and metabolic activity of the CYP3A subfamily in female rats.
    Aiba T; Yoshinaga M; Ishida K; Takehara Y; Hashimoto Y
    Biol Pharm Bull; 2005 Feb; 28(2):311-5. PubMed ID: 15684490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of piperine and quercetin alone or in combination with marbofloxacin on CYP3A37 and MDR1 mRNA expression levels in broiler chickens.
    Patel HB; Patel UD; Mathapati BS; Modi CM
    Res Vet Sci; 2019 Oct; 126():178-183. PubMed ID: 31539794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective induction of intestinal CYP3A23 by 1alpha,25-dihydroxyvitamin D3 in rats.
    Xu Y; Iwanaga K; Zhou C; Cheesman MJ; Farin F; Thummel KE
    Biochem Pharmacol; 2006 Jul; 72(3):385-92. PubMed ID: 16769037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential pharmacokinetic effect of rifampicin on enrofloxacin in broilers: Roles of P-glycoprotein and BCRP induction by rifampicin.
    Guo M; Dai X; Hu D; Zhang Y; Sun Y; Ren W; Wang L
    Poult Sci; 2016 Sep; 95(9):2129-35. PubMed ID: 27118859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression of CYP3A isoforms in equine liver and intestines.
    Tydén E; Löfgren M; Pegolo S; Capolongo F; Tjälve H; Larsson P
    J Vet Pharmacol Ther; 2012 Dec; 35(6):588-95. PubMed ID: 22283590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute quantification and modulation of cytochrome P450 3A isoforms in cattle liver.
    Zancanella V; Giantin M; Dacasto M
    Vet J; 2014 Oct; 202(1):106-11. PubMed ID: 25193407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.
    Tsunoda SM; Velez RL; von Moltke LL; Greenblatt DJ
    Clin Pharmacol Ther; 1999 Nov; 66(5):461-71. PubMed ID: 10579473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E. coli infection modulates the pharmacokinetics of oral enrofloxacin by targeting P-glycoprotein in small intestine and CYP450 3A in liver and kidney of broilers.
    Guo M; Sun Y; Zhang Y; Bughio S; Dai X; Ren W; Wang L
    PLoS One; 2014; 9(1):e87781. PubMed ID: 24498193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine.
    Martignoni M; Groothuis G; de Kanter R
    Drug Metab Dispos; 2006 Jun; 34(6):1047-54. PubMed ID: 16565172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic effects of dietary exposure to T-2 toxin on intestinal and hepatic biotransformation enzymes and drug transporter systems in broiler chickens.
    Osselaere A; Li SJ; De Bock L; Devreese M; Goossens J; Vandenbroucke V; Van Bocxlaer J; Boussery K; Pasmans F; Martel A; De Backer P; Croubels S
    Food Chem Toxicol; 2013 May; 55():150-5. PubMed ID: 23313610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes in the protein and mRNA levels of CYP2E1 and CYP3A isoforms as well as in their hepatic activities in Wistar rats. What role for oxidative stress?
    Wauthier V; Verbeeck RK; Buc Calderon P
    Arch Toxicol; 2004 Mar; 78(3):131-8. PubMed ID: 14600803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 3A expression and activity in the rabbit lacrimal gland: glucocorticoid modulation and the impact on androgen metabolism.
    Attar M; Ling KH; Tang-Liu DD; Neamati N; Lee VH
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4697-706. PubMed ID: 16303967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trans-chromosomic mice containing a human CYP3A cluster for prediction of xenobiotic metabolism in humans.
    Kazuki Y; Kobayashi K; Aueviriyavit S; Oshima T; Kuroiwa Y; Tsukazaki Y; Senda N; Kawakami H; Ohtsuki S; Abe S; Takiguchi M; Hoshiya H; Kajitani N; Takehara S; Kubo K; Terasaki T; Chiba K; Tomizuka K; Oshimura M
    Hum Mol Genet; 2013 Feb; 22(3):578-92. PubMed ID: 23125282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 3A mRNA expression along goat and rat gastrointestinal tracts.
    Mureithi D; Darwish WS; Ikenaka Y; Kanja L; Ishizuka M
    Jpn J Vet Res; 2012 Nov; 60(4):205-10. PubMed ID: 23304981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a fluorescent substrate for the selective quantification of rat CYP3A in the liver and the intestine.
    Michaud J; Leblond FA; Naud J; Boisvert C; Desbiens K; Nicoll-Griffith DA; Pichette V
    J Pharmacol Toxicol Methods; 2007; 55(2):209-13. PubMed ID: 16979351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daikenchuto (TU-100) alters murine hepatic and intestinal drug metabolizing enzymes in an in vivo dietary model: effects of gender and withdrawal.
    Nobutani K; Miyoshi J; Musch MW; Nishiyama M; Watanabe J; Kaneko A; Yamamoto M; Yoshida M; Kono T; Jeong H; Chang EB
    Pharmacol Res Perspect; 2017 Oct; 5(5):. PubMed ID: 28971602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.